Pre-order Enquiry
Request Free Sample
Global Migraine Headache Drugs Market Research Report 2023
SKU ID : QYR-23601830 | Publishing Date : 19-Apr-2023
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Migraine Headache Drugs Market Research Report 2023
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Migraine Headache Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Almotriptan
1.2.3 Eletriptan
1.2.4 Sumatriptan
1.2.5 Rizatriptan
1.2.6 Zolmitriptan
1.2.7 Naratriptan
1.2.8 Frovatriptan
1.2.9 Others
1.3 Market by Application
1.3.1 Global Migraine Headache Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Acute Migraine
1.3.3 Common Migraine
1.3.4 Classic Migraine
1.3.5 Chronic Migraine
1.3.6 Other Migraines
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Migraine Headache Drugs Market Perspective (2018-2029)
2.2 Migraine Headache Drugs Growth Trends by Region
2.2.1 Global Migraine Headache Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Migraine Headache Drugs Historic Market Size by Region (2018-2023)
2.2.3 Migraine Headache Drugs Forecasted Market Size by Region (2024-2029)
2.3 Migraine Headache Drugs Market Dynamics
2.3.1 Migraine Headache Drugs Industry Trends
2.3.2 Migraine Headache Drugs Market Drivers
2.3.3 Migraine Headache Drugs Market Challenges
2.3.4 Migraine Headache Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Migraine Headache Drugs Players by Revenue
3.1.1 Global Top Migraine Headache Drugs Players by Revenue (2018-2023)
3.1.2 Global Migraine Headache Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Migraine Headache Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Migraine Headache Drugs Revenue
3.4 Global Migraine Headache Drugs Market Concentration Ratio
3.4.1 Global Migraine Headache Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Migraine Headache Drugs Revenue in 2022
3.5 Migraine Headache Drugs Key Players Head office and Area Served
3.6 Key Players Migraine Headache Drugs Product Solution and Service
3.7 Date of Enter into Migraine Headache Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Migraine Headache Drugs Breakdown Data by Type
4.1 Global Migraine Headache Drugs Historic Market Size by Type (2018-2023)
4.2 Global Migraine Headache Drugs Forecasted Market Size by Type (2024-2029)
5 Migraine Headache Drugs Breakdown Data by Application
5.1 Global Migraine Headache Drugs Historic Market Size by Application (2018-2023)
5.2 Global Migraine Headache Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Migraine Headache Drugs Market Size (2018-2029)
6.2 North America Migraine Headache Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Migraine Headache Drugs Market Size by Country (2018-2023)
6.4 North America Migraine Headache Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Migraine Headache Drugs Market Size (2018-2029)
7.2 Europe Migraine Headache Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Migraine Headache Drugs Market Size by Country (2018-2023)
7.4 Europe Migraine Headache Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Migraine Headache Drugs Market Size (2018-2029)
8.2 Asia-Pacific Migraine Headache Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Migraine Headache Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Migraine Headache Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Migraine Headache Drugs Market Size (2018-2029)
9.2 Latin America Migraine Headache Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Migraine Headache Drugs Market Size by Country (2018-2023)
9.4 Latin America Migraine Headache Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Migraine Headache Drugs Market Size (2018-2029)
10.2 Middle East & Africa Migraine Headache Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Migraine Headache Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Migraine Headache Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Migraine Headache Drugs Introduction
11.1.4 Pfizer Revenue in Migraine Headache Drugs Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Migraine Headache Drugs Introduction
11.2.4 Novartis Revenue in Migraine Headache Drugs Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Migraine Headache Drugs Introduction
11.3.4 Johnson & Johnson Revenue in Migraine Headache Drugs Business (2018-2023)
11.3.5 Johnson & Johnson Recent Development
11.4 GSK
11.4.1 GSK Company Detail
11.4.2 GSK Business Overview
11.4.3 GSK Migraine Headache Drugs Introduction
11.4.4 GSK Revenue in Migraine Headache Drugs Business (2018-2023)
11.4.5 GSK Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Migraine Headache Drugs Introduction
11.5.4 Merck Revenue in Migraine Headache Drugs Business (2018-2023)
11.5.5 Merck Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Detail
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Migraine Headache Drugs Introduction
11.6.4 Eli Lilly Revenue in Migraine Headache Drugs Business (2018-2023)
11.6.5 Eli Lilly Recent Development
11.7 Teva
11.7.1 Teva Company Detail
11.7.2 Teva Business Overview
11.7.3 Teva Migraine Headache Drugs Introduction
11.7.4 Teva Revenue in Migraine Headache Drugs Business (2018-2023)
11.7.5 Teva Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Detail
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Migraine Headache Drugs Introduction
11.8.4 AstraZeneca Revenue in Migraine Headache Drugs Business (2018-2023)
11.8.5 AstraZeneca Recent Development
11.9 Sun Pharma
11.9.1 Sun Pharma Company Detail
11.9.2 Sun Pharma Business Overview
11.9.3 Sun Pharma Migraine Headache Drugs Introduction
11.9.4 Sun Pharma Revenue in Migraine Headache Drugs Business (2018-2023)
11.9.5 Sun Pharma Recent Development
11.10 Grunenthal
11.10.1 Grunenthal Company Detail
11.10.2 Grunenthal Business Overview
11.10.3 Grunenthal Migraine Headache Drugs Introduction
11.10.4 Grunenthal Revenue in Migraine Headache Drugs Business (2018-2023)
11.10.5 Grunenthal Recent Development
11.11 Endo Pharmaceuticals
11.11.1 Endo Pharmaceuticals Company Detail
11.11.2 Endo Pharmaceuticals Business Overview
11.11.3 Endo Pharmaceuticals Migraine Headache Drugs Introduction
11.11.4 Endo Pharmaceuticals Revenue in Migraine Headache Drugs Business (2018-2023)
11.11.5 Endo Pharmaceuticals Recent Development
11.12 Mylan
11.12.1 Mylan Company Detail
11.12.2 Mylan Business Overview
11.12.3 Mylan Migraine Headache Drugs Introduction
11.12.4 Mylan Revenue in Migraine Headache Drugs Business (2018-2023)
11.12.5 Mylan Recent Development
11.13 Bayer
11.13.1 Bayer Company Detail
11.13.2 Bayer Business Overview
11.13.3 Bayer Migraine Headache Drugs Introduction
11.13.4 Bayer Revenue in Migraine Headache Drugs Business (2018-2023)
11.13.5 Bayer Recent Development
11.14 Amneal Pharmaceuticals
11.14.1 Amneal Pharmaceuticals Company Detail
11.14.2 Amneal Pharmaceuticals Business Overview
11.14.3 Amneal Pharmaceuticals Migraine Headache Drugs Introduction
11.14.4 Amneal Pharmaceuticals Revenue in Migraine Headache Drugs Business (2018-2023)
11.14.5 Amneal Pharmaceuticals Recent Development
11.15 Apotex
11.15.1 Apotex Company Detail
11.15.2 Apotex Business Overview
11.15.3 Apotex Migraine Headache Drugs Introduction
11.15.4 Apotex Revenue in Migraine Headache Drugs Business (2018-2023)
11.15.5 Apotex Recent Development
11.16 Ajanta Pharma
11.16.1 Ajanta Pharma Company Detail
11.16.2 Ajanta Pharma Business Overview
11.16.3 Ajanta Pharma Migraine Headache Drugs Introduction
11.16.4 Ajanta Pharma Revenue in Migraine Headache Drugs Business (2018-2023)
11.16.5 Ajanta Pharma Recent Development
11.17 Allergan
11.17.1 Allergan Company Detail
11.17.2 Allergan Business Overview
11.17.3 Allergan Migraine Headache Drugs Introduction
11.17.4 Allergan Revenue in Migraine Headache Drugs Business (2018-2023)
11.17.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Migraine Headache Drugs Market Research Report 2023
List of TablesTable 1. Global Migraine Headache Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Almotriptan
Table 3. Key Players of Eletriptan
Table 4. Key Players of Sumatriptan
Table 5. Key Players of Rizatriptan
Table 6. Key Players of Zolmitriptan
Table 7. Key Players of Naratriptan
Table 8. Key Players of Frovatriptan
Table 9. Key Players of Others
Table 10. Global Migraine Headache Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 11. Global Migraine Headache Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 12. Global Migraine Headache Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 13. Global Migraine Headache Drugs Market Share by Region (2018-2023)
Table 14. Global Migraine Headache Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 15. Global Migraine Headache Drugs Market Share by Region (2024-2029)
Table 16. Migraine Headache Drugs Market Trends
Table 17. Migraine Headache Drugs Market Drivers
Table 18. Migraine Headache Drugs Market Challenges
Table 19. Migraine Headache Drugs Market Restraints
Table 20. Global Migraine Headache Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 21. Global Migraine Headache Drugs Market Share by Players (2018-2023)
Table 22. Global Top Migraine Headache Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Headache Drugs as of 2022)
Table 23. Ranking of Global Top Migraine Headache Drugs Companies by Revenue (US$ Million) in 2022
Table 24. Global 5 Largest Players Market Share by Migraine Headache Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Migraine Headache Drugs Product Solution and Service
Table 27. Date of Enter into Migraine Headache Drugs Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Migraine Headache Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 30. Global Migraine Headache Drugs Revenue Market Share by Type (2018-2023)
Table 31. Global Migraine Headache Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 32. Global Migraine Headache Drugs Revenue Market Share by Type (2024-2029)
Table 33. Global Migraine Headache Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 34. Global Migraine Headache Drugs Revenue Market Share by Application (2018-2023)
Table 35. Global Migraine Headache Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 36. Global Migraine Headache Drugs Revenue Market Share by Application (2024-2029)
Table 37. North America Migraine Headache Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Migraine Headache Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Migraine Headache Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Migraine Headache Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Europe Migraine Headache Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 42. Europe Migraine Headache Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 43. Asia-Pacific Migraine Headache Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 44. Asia-Pacific Migraine Headache Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 45. Asia-Pacific Migraine Headache Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 46. Latin America Migraine Headache Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Latin America Migraine Headache Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 48. Latin America Migraine Headache Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 49. Middle East & Africa Migraine Headache Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 50. Middle East & Africa Migraine Headache Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 51. Middle East & Africa Migraine Headache Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 52. Pfizer Company Detail
Table 53. Pfizer Business Overview
Table 54. Pfizer Migraine Headache Drugs Product
Table 55. Pfizer Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million)
Table 56. Pfizer Recent Development
Table 57. Novartis Company Detail
Table 58. Novartis Business Overview
Table 59. Novartis Migraine Headache Drugs Product
Table 60. Novartis Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million)
Table 61. Novartis Recent Development
Table 62. Johnson & Johnson Company Detail
Table 63. Johnson & Johnson Business Overview
Table 64. Johnson & Johnson Migraine Headache Drugs Product
Table 65. Johnson & Johnson Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million)
Table 66. Johnson & Johnson Recent Development
Table 67. GSK Company Detail
Table 68. GSK Business Overview
Table 69. GSK Migraine Headache Drugs Product
Table 70. GSK Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million)
Table 71. GSK Recent Development
Table 72. Merck Company Detail
Table 73. Merck Business Overview
Table 74. Merck Migraine Headache Drugs Product
Table 75. Merck Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million)
Table 76. Merck Recent Development
Table 77. Eli Lilly Company Detail
Table 78. Eli Lilly Business Overview
Table 79. Eli Lilly Migraine Headache Drugs Product
Table 80. Eli Lilly Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million)
Table 81. Eli Lilly Recent Development
Table 82. Teva Company Detail
Table 83. Teva Business Overview
Table 84. Teva Migraine Headache Drugs Product
Table 85. Teva Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million)
Table 86. Teva Recent Development
Table 87. AstraZeneca Company Detail
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Migraine Headache Drugs Product
Table 90. AstraZeneca Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million)
Table 91. AstraZeneca Recent Development
Table 92. Sun Pharma Company Detail
Table 93. Sun Pharma Business Overview
Table 94. Sun Pharma Migraine Headache Drugs Product
Table 95. Sun Pharma Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million)
Table 96. Sun Pharma Recent Development
Table 97. Grunenthal Company Detail
Table 98. Grunenthal Business Overview
Table 99. Grunenthal Migraine Headache Drugs Product
Table 100. Grunenthal Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million)
Table 101. Grunenthal Recent Development
Table 102. Endo Pharmaceuticals Company Detail
Table 103. Endo Pharmaceuticals Business Overview
Table 104. Endo Pharmaceuticals Migraine Headache Drugs Product
Table 105. Endo Pharmaceuticals Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million)
Table 106. Endo Pharmaceuticals Recent Development
Table 107. Mylan Company Detail
Table 108. Mylan Business Overview
Table 109. Mylan Migraine Headache Drugs Product
Table 110. Mylan Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million)
Table 111. Mylan Recent Development
Table 112. Bayer Company Detail
Table 113. Bayer Business Overview
Table 114. Bayer Migraine Headache Drugs Product
Table 115. Bayer Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million)
Table 116. Bayer Recent Development
Table 117. Amneal Pharmaceuticals Company Detail
Table 118. Amneal Pharmaceuticals Business Overview
Table 119. Amneal Pharmaceuticals Migraine Headache Drugs Product
Table 120. Amneal Pharmaceuticals Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million)
Table 121. Amneal Pharmaceuticals Recent Development
Table 122. Apotex Company Detail
Table 123. Apotex Business Overview
Table 124. Apotex Migraine Headache Drugs Product
Table 125. Apotex Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million)
Table 126. Apotex Recent Development
Table 127. Ajanta Pharma Company Detail
Table 128. Ajanta Pharma Business Overview
Table 129. Ajanta Pharma Migraine Headache Drugs Product
Table 130. Ajanta Pharma Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million)
Table 131. Ajanta Pharma Recent Development
Table 132. Allergan Company Detail
Table 133. Allergan Business Overview
Table 134. Allergan Migraine Headache Drugs Product
Table 135. Allergan Revenue in Migraine Headache Drugs Business (2018-2023) & (US$ Million)
Table 136. Allergan Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Migraine Headache Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Migraine Headache Drugs Market Share by Type: 2022 VS 2029
Figure 3. Almotriptan Features
Figure 4. Eletriptan Features
Figure 5. Sumatriptan Features
Figure 6. Rizatriptan Features
Figure 7. Zolmitriptan Features
Figure 8. Naratriptan Features
Figure 9. Frovatriptan Features
Figure 10. Others Features
Figure 11. Global Migraine Headache Drugs Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 12. Global Migraine Headache Drugs Market Share by Application: 2022 VS 2029
Figure 13. Acute Migraine Case Studies
Figure 14. Common Migraine Case Studies
Figure 15. Classic Migraine Case Studies
Figure 16. Chronic Migraine Case Studies
Figure 17. Other Migraines Case Studies
Figure 18. Migraine Headache Drugs Report Years Considered
Figure 19. Global Migraine Headache Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 20. Global Migraine Headache Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 21. Global Migraine Headache Drugs Market Share by Region: 2022 VS 2029
Figure 22. Global Migraine Headache Drugs Market Share by Players in 2022
Figure 23. Global Top Migraine Headache Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Headache Drugs as of 2022)
Figure 24. The Top 10 and 5 Players Market Share by Migraine Headache Drugs Revenue in 2022
Figure 25. North America Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. North America Migraine Headache Drugs Market Share by Country (2018-2029)
Figure 27. United States Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Canada Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Europe Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Europe Migraine Headache Drugs Market Share by Country (2018-2029)
Figure 31. Germany Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. France Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. U.K. Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Italy Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Russia Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Nordic Countries Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Asia-Pacific Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Asia-Pacific Migraine Headache Drugs Market Share by Region (2018-2029)
Figure 39. China Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Japan Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Southeast Asia Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. India Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Australia Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Latin America Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Latin America Migraine Headache Drugs Market Share by Country (2018-2029)
Figure 47. Mexico Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Brazil Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Migraine Headache Drugs Market Share by Country (2018-2029)
Figure 51. Turkey Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Migraine Headache Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Pfizer Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023)
Figure 54. Novartis Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023)
Figure 55. Johnson & Johnson Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023)
Figure 56. GSK Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023)
Figure 57. Merck Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023)
Figure 58. Eli Lilly Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023)
Figure 59. Teva Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023)
Figure 60. AstraZeneca Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023)
Figure 61. Sun Pharma Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023)
Figure 62. Grunenthal Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023)
Figure 63. Endo Pharmaceuticals Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023)
Figure 64. Mylan Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023)
Figure 65. Bayer Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023)
Figure 66. Amneal Pharmaceuticals Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023)
Figure 67. Apotex Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023)
Figure 68. Ajanta Pharma Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023)
Figure 69. Allergan Revenue Growth Rate in Migraine Headache Drugs Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Keyplayers in Global Migraine Headache Drugs Market Research Report 2023
PfizerNovartis
Johnson & Johnson
GSK
Merck
Eli Lilly
Teva
AstraZeneca
Sun Pharma
Grunenthal
Endo Pharmaceuticals
Mylan
Bayer
Amneal Pharmaceuticals
Apotex
Ajanta Pharma
Allergan
